XenoPort, Inc. (XNPT) Presents New Analyses Of Data For Gabapentin Enacarbil At The 33rd Annual Scientific Meeting Of The American Pain Society
4/30/2014 9:09:30 AM
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will present new analyses of data for gabapentin enacarbil (GEn), the active ingredient in HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, at the 33rd Annual Scientific Meeting of the American Pain Society (APS) in Tampa, Florida.
Help employers find you! Check out all the jobs and post your resume.
comments powered by